ADC Therapeutics SA
NYSE:ADCT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ADC Therapeutics SA
NYSE:ADCT
|
CH |
|
A
|
Asahi Kasei Corp
XMUN:ASAA
|
JP |
|
J
|
Joong Ang Enervis Co Ltd
KOSDAQ:000440
|
KR |
|
W
|
West Fraser Timber Co Ltd
XMUN:WFC
|
CA |
|
S
|
Svenska Cellulosa SCA AB
SWB:SCA1
|
SE |
|
Nippon Sanso Holdings Corp
OTC:TYNPF
|
JP |
|
C
|
Coca-Cola Europacific Partners PLC
F:CK0
|
UK |
|
F
|
First Tractor Co Ltd
XMUN:FTP
|
CN |
|
Regeneron Pharmaceuticals Inc
LSE:0R2M
|
US |
Wall St Price Targets
ADCT Price Targets Summary
ADC Therapeutics SA
According to Wall Street analysts, the average 1-year price target for ADCT is 4.85 USD with a low forecast of 0.51 USD and a high forecast of 10.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ADCT's stock price target?
Price Target
4.85
USD
According to Wall Street analysts, the average 1-year price target for ADCT is 4.85 USD with a low forecast of 0.51 USD and a high forecast of 10.5 USD.
What is the Revenue forecast for ADC Therapeutics SA?
Projected CAGR
38%
Over the last 7 years, the compound annual growth rate for Revenue has been 85%. The projected CAGR for the next 3 years is 38%.
What is the Gross Profit forecast for ADC Therapeutics SA?
Projected CAGR
53%
The compound annual growth rate for Gross Profit over the next 3 years is 53%.
